Del. Justices Uphold Toss Of Salix-Valeant Merger Appeal
Investor attorneys were shut down Thursday in their bid to save a challenge to the $13.1 billion merger of Salix Pharmaceuticals and Valeant Pharmaceuticals, with Delaware's Supreme Court upholding without new comment...To view the full article, register now.
Already a subscriber? Click here to view full article